Neural Regeneration Research ›› 2026, Vol. 21 ›› Issue (8): 3323-3331.doi: 10.4103/NRR.NRR-D-24-01313

Previous Articles     Next Articles

The arginine–phenylalanine–amide neuropeptide receptor family: Physiological effects, drug development, and structural insight

Yiming Liu1, #, Shirui Jiang2, #, Zhangsong Wu1, 2, Chen Qiu1, Qiaohui Li3, Rui Wang1, Xiaoyi Yan1, Song Wu2, *, Geng Chen1, *, Yang Du1, *   

  1. 1Kobilka Institute of Innovative Drug Discovery, Shenzhen Key Laboratory of Steroid Drug Discovery and Development, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong Province, China; 
    2The Huanan Affiliated Hospital of Shenzhen University, Shenzhen University, Shenzhen, Guangdong Province, China; 
    3Biological Science Research Center, Academy for Advanced Interdisciplinary Studies, Southwest University, Chongqing, China
  • Online:2026-08-18 Published:2026-04-23
  • Contact: Yang Du, PhD, yangdu@cuhk.edu.cn; Geng Chen, PhD, chengeng@cuhk.edu.cn; Song Wu, MD, wusong@szu.edu.cn.
  • Supported by:
    This work was supported by the Shenzhen Science and Technology Innovation Commission, No. JCYJ20220818103009018 (to YD).

Abstract: The arginine–phenylalanine–amide neuropeptide receptor family comprises a subclass within the G protein-coupled receptor superfamily with crucial roles in physiological regulation. These receptors recognize and bind neuropeptides with an arginine–phenylalanine–amide motif, thereby participating in a variety of biological processes such as energy metabolism, pain perception, and reproductive functions. In this review, we explore the physiological and pathological processes involving these receptors and delve into the structure-activity relationships of their ligand peptides, clarifying the key structural motifs within these neuropeptides that determine their biological activity, pharmacological potency, and receptor selectivity. Particular emphasis is placed on their roles in modulating nociception, regulating appetite, and maintaining reproductive health. Additionally, we discuss the therapeutic potential of structure-based drug design targeting these receptors based on existing cryo-electron microscopy structures. The available structural insights into ligand-binding pockets and G protein–receptor interaction interfaces provide a clear perspective and valuable complement to ligand optimization.

Key words: appetite regulation, arginine–phenylalanine–amide, drug discovery, G protein-coupled receptor,  , neuropeptides, nerve regeneration, pain modulation, structure–activity relationship